Similar articles for PMID: 23898100

Year	Number of Results
1986	1
1995	2
1997	2
1998	1
1999	1
2000	2
2001	1
2002	2
2003	2
2004	8
2005	3
2006	4
2007	6
2008	9
2009	11
2010	8
2011	10
2012	12
2013	17
2014	10
2015	14
2016	15
2017	13
2018	10
2019	10
2020	3
2021	4
2022	3
2023	2
2024	0

1

Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.

Yamauchi T, Negoro E, Lee S, Takai M, Matsuda Y, Takagi K, Kishi S, Tai K, Hosono N, Tasaki T, Ikegaya S, Yoshida A, Urasaki Y, Iwasaki H, Ueda T. Yamauchi T, et al. Anticancer Res. 2013 Aug;33(8):3335-40. Anticancer Res. 2013. PMID: 23898100

2

Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.

Messina C, Candoni A, Carrabba MG, Tresoldi C, Sala E, Tassara M, Crippa A, Peccatori J, Assanelli A, Gattillo S, Bellio L, Fanin R, Ciceri F, Bernardi M. Messina C, et al. Biol Blood Marrow Transplant. 2014 Oct;20(10):1586-91. doi: 10.1016/j.bbmt.2014.06.017. Epub 2014 Jun 18. Biol Blood Marrow Transplant. 2014. PMID: 24954546 Free article.

3

Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.

Siehl JM, Reinwald M, Heufelder K, Menssen HD, Keilholz U, Thiel E. Siehl JM, et al. Ann Hematol. 2004 Dec;83(12):745-50. doi: 10.1007/s00277-004-0941-0. Epub 2004 Aug 31. Ann Hematol. 2004. PMID: 15340762

4

Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.

Galimberti S, Guerrini F, Carulli G, Fazzi R, Palumbo GA, Morabito F, Petrini M. Galimberti S, et al. Eur J Haematol. 2004 Jan;72(1):45-51. doi: 10.1046/j.0902-4441.2003.00185.x. Eur J Haematol. 2004. PMID: 14962262

5

Reduction in WT1 gene expression during early treatment predicts the outcome in patients with acute myeloid leukemia.

Andersson C, Li X, Lorenz F, Golovleva I, Wahlin A, Li A. Andersson C, et al. Diagn Mol Pathol. 2012 Dec;21(4):225-33. doi: 10.1097/PDM.0b013e318257ddb9. Diagn Mol Pathol. 2012. PMID: 23111196

6

Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.

Kim HJ, Choi EJ, Sohn HJ, Park SH, Min WS, Kim TG. Kim HJ, et al. Eur J Haematol. 2013 Nov;91(5):411-22. doi: 10.1111/ejh.12167. Epub 2013 Sep 18. Eur J Haematol. 2013. PMID: 23826993

7

Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.

Candoni A, Toffoletti E, Gallina R, Simeone E, Chiozzotto M, Volpetti S, Fanin R. Candoni A, et al. Clin Transplant. 2011 Mar-Apr;25(2):308-16. doi: 10.1111/j.1399-0012.2010.01251.x. Clin Transplant. 2011. PMID: 20412098

8

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss T, Izzo B, Nomdedeu J, van der Heijden A, van der Reijden BA, Jansen JH, van der Velden VH, Ommen H, Preudhomme C, Saglio G, Grimwade D. Cilloni D, et al. J Clin Oncol. 2009 Nov 1;27(31):5195-201. doi: 10.1200/JCO.2009.22.4865. Epub 2009 Sep 14. J Clin Oncol. 2009. PMID: 19752335

9

Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.

Kwon M, Martínez-Laperche C, Infante M, Carretero F, Balsalobre P, Serrano D, Gayoso J, Pérez-Corral A, Anguita J, Díez-Martín JL, Buño I. Kwon M, et al. Biol Blood Marrow Transplant. 2012 Aug;18(8):1235-42. doi: 10.1016/j.bbmt.2012.01.012. Epub 2012 Jan 25. Biol Blood Marrow Transplant. 2012. PMID: 22281301 Free article.

10

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.

Boublikova L, Kalinova M, Ryan J, Quinn F, O'Marcaigh A, Smith O, Browne P, Stary J, McCann SR, Trka J, Lawler M. Boublikova L, et al. Leukemia. 2006 Feb;20(2):254-63. doi: 10.1038/sj.leu.2404047. Leukemia. 2006. PMID: 16341043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year